April 07,2019
Pharma14 tracking of new cancer drug market authorizations.
2018 has seen a record number of new medicines approved by the FDA.
59 new novel drugs and biologics have been approved.
Combining 2017 and 2018, the FDA has approved well over 30 new cancer drugs.
As the number of new cancer drugs coming onto market is increasing each year, Pharma14 has undertaken a specific program to track and list these new products immediately as they become registered MA’s among the 39 countries we cover.
Sample data: Opdivo, Nivolumab 10 mg/ml. Ex-factory prices in selected markets.
